地夸磷索钠

Diquafosol

未知生产厂商

Diquafosol is a medication indicated to treat dry eyes associated with keratoconjunctival disorders.

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Diquafosol is a medication indicated to treat dry eyes associated with keratoconjunctival disorders.

适应症

用于经诊断为伴随泪液异常的角结膜上皮损伤的干眼病患者。

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Ophthalmic solution comprising diquafosol
US 9486529 B2申请人: SANTEN PHARMACEUTICAL CO LTD优先权: 2012
CN
EP
US
8 件公开
OPHTHALMIC COMPOSITION CONTAINING DIQUAFOSOL OR SALT THEREOF, VINYL-BASED POLYMER AND CELLULOSE-BASED POLYMER
US 2022054520 A1申请人: SANTEN PHARMACEUTICAL CO LTD优先权: 2019
CN
EP
US
WO
4 件公开
COMBINATION PREPARATION CONTAINING HETEROCYCLIDENE ACETAMIDE DERIVATIVE
EP 4595960 A1申请人: SENJU PHARMA CO优先权: 2022
CN
EP
US
WO
4 件公开
OPHTHALMIC COMPOSITION COMPRISING DIQUAFOSOL AND CATIONIC POLYMER
EP 3760207 A4申请人: SANTEN PHARMACEUTICAL CO LTD优先权: 2018
CN
EP
WO
4 件公开
Therapeutic agent for dry eye characterized by being applied to eye of dry eye patient wearing soft contact lens
US 10729712 B2申请人: SANTEN PHARMACEUTICAL CO LTD优先权: 2015
CN
US
4 件公开
DIQUAFOSOL OR SALT THEREOF, AND AQUEOUS OPHTHALMIC COMPOSITION CONTAINING POLYVINYLPYRROLIDONE
WO 2021039748 A1申请人: SANTEN PHARMACEUTICAL CO LTD优先权: 2019
CN
WO
3 件公开
OPHTHALMIC SOLUTION COMPRISING DIQUAFOSOL, METHOD FOR PRODUCING THE SAME, AND METHOD FOR INHIBITING FORMATION OF INSOLUBLE PRECIPITATE
US 2014221306 A1申请人: SAKATANI AKIKO优先权: 2010
CN
US
2 件公开
OPHTHALMIC COMPOSITION COMPRISING DIQUAFOSOL
- WO 2021261930 A1
  申请人: TAEJOON PHARMACEUTICAL CO LTD优先权: 2020
  CN
  WO
  2 件公开
- CN 115701986 A
  申请人: TAEJOON PHARMACEUTICAL CO LTD优先权: 2020
  CN
Aqueous ophthalmic solution
US 10278985 B2申请人: SANTEN PHARMACEUTICAL CO LTD优先权: 2014
US
2 件公开
Chelating agent-containing diquafosol tetrasodium eye drop
CN 108403625 A申请人: DONGGUAN XIESHI MEDICINE TECH CO LTD优先权: 2018
CN

药物

地夸磷索钠

概览

适应症

相关疾病

专利

OPHTHALMIC COMPOSITION COMPRISING DIQUAFOSOL